Employers Signal Moves to Drop GLP-1 Weight-Loss Coverage in 2027 as Use Rises
A portion of U.S. employers that currently cover GLP-1 medications for weight loss are planning to end coverage in 2027, citing growing patient numbers and persistent cost differences between direct-to-consumer pricing and employer contracts negotiated through pharmacy benefit managers. Surveys of large employers and statements from industry figure…